SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:
SEC Accession No. 0001193125-24-024104
Filing Date
2024-02-05
Accepted
2024-02-05 16:35:07
Documents
8
Effectiveness Date
2024-02-05

Document Format Files

Seq Description Document Type Size
1 S-3ASR d724647ds3asr.htm S-3ASR 222443
2 EX-4.3 d724647dex43.htm EX-4.3 290391
3 EX-5.1 d724647dex51.htm EX-5.1 25693
4 EX-23.2 d724647dex232.htm EX-23.2 1566
5 EX-FILING FEES d724647dexfilingfees.htm EX-FILING FEES 27935
6 GRAPHIC g724647g00w78.jpg GRAPHIC 591674
7 GRAPHIC g724647g0203114538767.jpg GRAPHIC 1802
8 GRAPHIC g724647g0203114539154.jpg GRAPHIC 2780
  Complete submission text file 0001193125-24-024104.txt   1383070
Mailing Address 5858 HORTON STREET #455 EMERYVILLE CA 94608
Business Address 5858 HORTON STREET #455 EMERYVILLE CA 94608 5105052680
4D Molecular Therapeutics, Inc. (Filer) CIK: 0001650648 (see all company filings)

IRS No.: 473506994 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3ASR | Act: 33 | File No.: 333-276872 | Film No.: 24596247
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)